2020
DOI: 10.1101/2020.09.09.20178764
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Metagenomic sequencing to detect respiratory viruses in persons under investigation for COVID-19

Abstract: We used metagenomic next-generation sequencing (mNGS) to assess the frequencies of alternative viral infections in SARS-CoV-2 RT-PCR negative persons under investigations (PUIs) (n=30) and viral co-infections in SARS-CoV-2 RT-PCR positive PUIs (n=45). mNGS identified both co-infections and alternative viral infections that were not detected by routine clinical workup

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…Samples underwent DNAse treatment (ArcticZymes), cDNA synthesis with random primers and Superscript III (Invitrogen), Nextera XT tagmentation (Illumina), and Illumina sequencing ( Babiker et al. 2020a ).…”
Section: Methodsmentioning
confidence: 99%
“…Samples underwent DNAse treatment (ArcticZymes), cDNA synthesis with random primers and Superscript III (Invitrogen), Nextera XT tagmentation (Illumina), and Illumina sequencing ( Babiker et al. 2020a ).…”
Section: Methodsmentioning
confidence: 99%
“…Samples underwent DNAse treatment (ArcticZymes), cDNA synthesis with random primers and Superscript III (Invitrogen), Nextera XT tagmentation (Illumina), and Illumina sequencing 35 . A median of 36.4 million reads were obtained per sample.…”
Section: Sars-cov-2 Genome Sequencingmentioning
confidence: 99%
“…mNGS can theoretically detect all pathogens in clinical samples and is especially suitable for detecting complex, rare, novel, and atypical infectious diseases ( Ge et al, 2021 ). In particular for some viruses, mNGS might be the only feasible method of detection ( Babiker et al, 2020 ; van Boheemen et al, 2020 ). mNGS can be used for a variety of common clinical microbiology samples, such as cerebrospinal fluid, whole blood, alveolar lavage fluid, pus, and tissue ( Wilson et al, 2014 ; Doan et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%